Chu, H.H.; Kim, J.H.; Shim, J.H.; Gwon, D.I.; Ko, H.-K.; Shin, J.H.; Ko, G.-Y.; Yoon, H.-K.; Kim, N.
Neutrophil-to-Lymphocyte Ratio as a Biomarker Predicting Overall Survival after Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma. Cancers 2021, 13, 2830.
https://doi.org/10.3390/cancers13112830
AMA Style
Chu HH, Kim JH, Shim JH, Gwon DI, Ko H-K, Shin JH, Ko G-Y, Yoon H-K, Kim N.
Neutrophil-to-Lymphocyte Ratio as a Biomarker Predicting Overall Survival after Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma. Cancers. 2021; 13(11):2830.
https://doi.org/10.3390/cancers13112830
Chicago/Turabian Style
Chu, Hee Ho, Jin Hyoung Kim, Ju Hyun Shim, Dong Il Gwon, Heung-Kyu Ko, Ji Hoon Shin, Gi-Young Ko, Hyun-Ki Yoon, and Nayoung Kim.
2021. "Neutrophil-to-Lymphocyte Ratio as a Biomarker Predicting Overall Survival after Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma" Cancers 13, no. 11: 2830.
https://doi.org/10.3390/cancers13112830
APA Style
Chu, H. H., Kim, J. H., Shim, J. H., Gwon, D. I., Ko, H.-K., Shin, J. H., Ko, G.-Y., Yoon, H.-K., & Kim, N.
(2021). Neutrophil-to-Lymphocyte Ratio as a Biomarker Predicting Overall Survival after Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma. Cancers, 13(11), 2830.
https://doi.org/10.3390/cancers13112830
